Study of Metronomic Chemotherapy With Taxotere (Docetaxel) Plus Nexavar (Sorafenib) as First-Line Therapy for Patients With Advanced Non-Squamous Cell Non-Small Cell Lung Cancer
This study has been completed.
Study NCT00801801
Information provided by University of Alabama at Birmingham
First Received on December 2, 2008.
Last Updated on January 24, 2012
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
